Psychiatric Services and Prescription Fills Among Veterans With Serious Mental Illness in Methadone Maintenance Treatment

REFERENCES

• Anglin, M.D., Speckart, G.R., Booth, M.W., & Ryan, T.M. (1989). Consequences and costs of shutting off methadone. Addictive Behaviors, 14(3), 307–326.
   PubMed Web of Science ®Google Scholar
• Bogenschutz, M.P., & Siegfreid, S.L. (1998). Factors affecting engagement of dual diagnosis patients in outpatient treatment. Psychiatric Services, 49(10), 1350–1352.
   PubMed Web of Science ®Google Scholar
• Brooner, R.K., King, V.L., Kidorf, M., Schmidt, C.W., & Bigelow, G.E. (1997). Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry, 54(1), 71–80.
   PubMed Web of Science ®Google Scholar
• Brunette, M.F., & Mueser, K.T. (2006). Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder. Journal of Clinical Psychiatry, 67(Suppl 7), 10–17.
   PubMed Web of Science ®Google Scholar
• Centorrino, F., Hernán, M.A., Drago-Ferrante, G., Rendall, M., Apicella, A., Längar, G., & Baldessarini, R.J. (2001). Factors associated with noncompliance with psychiatric outpatient visits. Psychiatric Services, 52(3), 378–380doi:10.1176/appi.ps.52.3.378
   PubMed Web of Science ®Google Scholar
• Charlson, M.E., Pompei, P., Ales, K.L., & MacKenzie, C.R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383.
   PubMedGoogle Scholar
• Dole, V.P., Robinson, J.W., Orraca, J., Towns, E., Searcy, P., & Caine, E. (1969). Methadone treatment of randomly selected criminal addicts. New England Journal of Medicine, 280(25), 1372–1375doi:10.1056/NEJM196906192802502
   PubMed Web of Science ®Google Scholar
• Doran, K.M., Raven, M.C., & Rosenheck, R.A. (2013). What drives frequent emergency department use in an integrated health system? National data from the Veterans Health Administration. Annals of Emergency Medicine, 62(2), 151–159doi:10.1016/j.annemergmed.2013.02.016
   PubMed Web of Science ®Google Scholar
• Drake, R.E., Essock, S.M., Shaner, A., Carey, K.B., Minkoff, K., Kola, L., … Rickards, L. (2001). Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52(4), 469–476doi:10.1176/appi.ps.52.4.469
   PubMed Web of Science ®Google Scholar
• Evans, J.L., Tsui, J.I., Hahn, J.A., Davidson, P.J., Lum, P.J., & Page, K. (2012). Mortality among young injection drug users in San Francisco: A 10-year follow-up of the UFO study. American Journal of Epidemiology, 175(4), 302–308doi:10.1093/aje/kwr318
   PubMed Web of Science ®Google Scholar
• Fullerton, C.A., Kim, M., Thomas, C.P., Lyman, D.R., Montejano, L.B., Dougherty, R.H., … Delphin-Rittmon, M.E. (2014). Medication-assisted treatment with methadone: Assessing the evidence. Psychiatric Services, 65(2), 146–157doi:10.1176/appi.ps.201300235
   PubMed Web of Science ®Google Scholar
• Grant, B.F., Stinson, F.S., Dawson, D.A., Chou, S.P., Dufour, M.C., Compton, W., … Kaplan, K. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(8), 807–816doi:10.1001/archpsyc.61.8.807
   PubMed Web of Science ®Google Scholar
• Gruber, V.A., & McCance-Katz, E.F. (2010). Methadone, buprenorphine, and street drug interactions with antiretroviral medications. Current HIV/AIDS Reports, 7(3), 152–160doi:10.1007/s11904-010-0048-2
   PubMedGoogle Scholar
• Hser, Y.I., Hoffman, V., Grella, C.E., & Anglin, M.D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58(5), 503–508doi:10.1001/archpsyc.58.5.503
   PubMed Web of Science ®Google Scholar
• Macarthur, G.J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., … Hickman, M. (2012). Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis. BMJ, 345, e5945doi:10.1136/bmj.e5945
   PubMed Web of Science ®Google Scholar
• Marienfeld, C., & Rosenheck, R. (2013). National psychotropic prescription dispensation among dually diagnosed patients. Advances in Dual Diagnosis, 6(1), 34–44doi:10.1108/17570971311309015
   Google Scholar
• Mattick, R.P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. The Cochrane Database of Systematic Reviews, 3, CD002209doi:10.1002/14651858.CD002209.pub2
   PubMed Web of Science ®Google Scholar
• McCance-Katz, E.F., Sullivan, L.E., & Nallani, S. (2010). Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: A review. The American Journal on Addictions, 19(1), 4–16doi:10.1111/j.1521-0391.2009.00005.x
   PubMed Web of Science ®Google Scholar
• Olfson, M., Mechanic, D., Hansell, S., Boyer, C.A., Walkup, J., & Weiden, P.J. (2000). Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services, 51(2), 216–222doi:10.1176/appi.ps.51.2.216
   PubMed Web of Science ®Google Scholar
• Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487–497 doi:/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Ryan, C.F., & White, J.M. (1996). Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction, 91(1), 39–45.
   PubMed Web of Science ®Google Scholar
• Teter, C.J., Falone, A.E., Bakaian, A.M., Tu, C., Ongur, D., & Weiss, R.D. (2011). Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder. Psychiatry Research, 190(2–3), 253–258doi:10.1016/j.psychres.2011.05.042
   PubMed Web of Science ®Google Scholar
• Van Den Berg, C., Smit, C., Van Brussel, G., Coutinho, R., Prins, M., & Cohort, A. (2007). Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users. Addiction, 102(9), 1454–1462doi:10.1111/j.1360-0443.2007.01912.x
   PubMed Web of Science ®Google Scholar
• Weisner, C., Mertens, J., Parthasarathy, S., Moore, C., & Lu, Y. (2001). Integrating primary medical care with addiction treatment: A randomized controlled trial. JAMA: The Journal of the American Medical Association, 286(14), 1715–1723doi:10.1001/jama.286.14.1715
   PubMed Web of Science ®Google Scholar
• Wolpe, P.R., Gorton, G., Serota, R., & Sanford, B. (1993). Predicting compliance of dual diagnosis inpatients with aftercare treatment. Hospital & Community Psychiatry, 44(1), 45–49.
   PubMedGoogle Scholar